Sanofi (SNY) Tops Q2 EPS by EUR 0.14

Sanofi (NYSE: SNY) reported Q2 EPS of EUR1.84, EUR0.14 better than the analyst estimate of EUR1.70. Revenue for the quarter came in at EUR9.39 billion versus the consensus estimate of EUR9.26 billion.

For earnings history and earnings-related data on Sanofi (SNY) click here.

You May Also Be Interested In

• Novel Patented Myelin Drug-Discovery Strategy Targets Massive Unmet Need in Multiple Sclerosis
• Piper Sandler on Fervo Energy (FRVO): 'Capital Access Supports Potential Upside'
• Carnival Corp. (CCL) Tops Q2 EPS by 8c, Beats on Revenue; Offers Guidance